Kolding Sygehus

Kolding 6000

0 studies enrolling now · 7 studies all time

What they study most

COVID, COVID-19, Cardiovascular Disease, Coronary Heart Disease (CHD), Covid19, Diabetes Mellitus, Type 2, FSGS, SARS (Severe Acute Respiratory Syndrome), SARS-CoV-2, SARS-CoV2 Infection

Studies at this site

• A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
• Outpatient Treatment With Anti-Coronavirus Immunoglobulin — Paused
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Linagliptin as Add on to Basal Insulin in the Elderly — Completed